A majority of healthcare professionals responding to an online survey conducted by MedPage Today (http://www.MedPageToday.com) stated that they will not prescribe rosiglitazone (Avandia) for their patients with type 2 diabetes, and one in four believe that the drug should be pulled off the market.
More
No comments:
Post a Comment